In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vir launches and gets over $150mm in funding

Executive Summary

Vir Biotechnology Inc. has launched and is raising more than $150mm in Series A money. Lead investors were Arch Venture Partners, which itself committed $150mm, and the Bill & Melinda Gates Foundation, as well as sovereign wealth funds, public mutual funds, and individuals and family offices.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies